News in the Life Sciences Industry

First care center in Italy offers patients the latest technology breakthrough in personalized cancer care

STOCKHOLM, Nov. 5, 2019 /PRNewswire/ -- In December 2011, Karo Pharma Aktiebolag ("Karo Pharma") entered into a research collaboration and license agreement with Pfizer, with the purpose of discovering and developing substances that hamper the activity in the nuclear hormone receptor... Read more ››

STOCKHOLM, Nov. 5, 2019 /PRNewswire/ -- Q3

SEOUL, South Korea, Nov. 5, 2019 /PRNewswire/ -- Janssen Korea Ltd. and Johnson & Johnson Innovation LLC, in collaboration with the Seoul Metropolitan Government and Korea Health Industry Development Institute (KHIDI), today announced the awardees of the Read more ››

STOCKHOLM, Nov. 4, 2019 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today, on 4th November 2019, that the first patient has been screened for the company's clinical phase IIb study in prostate cancer, a study entitled RhoVac-002 ("BRaVac"). The screening took place at the Odense University... Read more ››

STOCKHOLM, Nov. 4, 2019 /PRNewswire/ -- Calliditas Therapeutics ("Calliditas") today hosts a Capital Markets Day in Stockholm, moderated by Lars Frick from Börsveckan.

SINGAPORE, Nov. 4, 2019 /PRNewswire/ -- Commissioned by Novartis Oncology, The Count Us, Know Us, Join Us Advanced Breast Cancer (ABC) survey today unveils valuable insights that put a spotlight on patients' perspectives as we conclude Breast Cancer Awareness Month. The survey, which was set... Read more ››

STOCKHOLM, Nov. 1, 2019 /PRNewswire/ -- SciBase today announces the first multi system order from a large dermatology practice group. Advanced Dermatology, P.C. is a group of over 40 dermatology practices in the New York tri-state area.

STOCKHOLM, Oct. 31, 2019 /PRNewswire/ -- Q-linea AB (publ) (Nasdaq Stockholm: QLINEA), to publish the company's Interim Report for the period January - September 2019 on Thursday, November 7, 2019 at 07:30 a.m. CET.

STOCKHOLM, Oct. 31, 2019 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm, ONCO) today announces that the number of shares and votes in Oncopeptides has changed as a result of exercise of warrants under the company's incentive programs.